CNS Pharmaceuticals Inc (CNSP) — Working Capital to Net Assets Ratio

Latest as of June 2026: 99.9%

CNS Pharmaceuticals Inc (CNSP) has a Working Capital to Net Assets ratio of 99.9% as of June 2026. Working capital of $18.18 Million (current assets of $21.92 Million minus current liabilities of $3.74 Million) is measured against net assets of $18.20 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See CNSP days of operational coverage to measure how many days the company can operate on defensive assets alone.

WC/NA Ratio

99.9%
Working Capital / Net Assets

Working Capital

$18.18 Million
USD

Current Assets

$21.92 Million
USD

Current Liabilities

$3.74 Million
USD

CNS Pharmaceuticals Inc Working Capital to Net Assets (2017–2025)

This chart shows how CNS Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 99.9%, reflecting working capital of $18.18 Million against net assets of $18.20 Million USD. For the complete balance sheet picture, see CNS Pharmaceuticals Inc assets under control.

Annual Working Capital to Net Assets for CNS Pharmaceuticals Inc (2017–2025)

The table below presents the year-by-year Working Capital to Net Assets ratio for CNS Pharmaceuticals Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read CNS Pharmaceuticals Inc total liabilities for a breakdown of total debt and financial obligations.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2025 88.5% $4.00 Million $4.52 Million $8.10 Million $4.10 Million ▼ -10.8 pp
2024 99.3% $6.13 Million $6.18 Million $8.66 Million $2.52 Million ▼ -3.2 pp
2023 102.5% $-4.54 Million $-4.43 Million $1.59 Million $6.13 Million ▲ +8.5 pp
2022 94.0% $7.64 Million $8.13 Million $12.56 Million $4.92 Million ▲ +13.3 pp
2021 80.7% $5.34 Million $6.62 Million $7.48 Million $2.14 Million ▼ -16.8 pp
2020 97.4% $13.59 Million $13.95 Million $15.50 Million $1.91 Million ▼ -2.3 pp
2019 99.8% $7.58 Million $7.60 Million $7.89 Million $311.00K ▼ -17.6 pp
2018 117.3% $-644.50K $-549.30K $588.13K $1.23 Million ▲ +17.3 pp
2017 100.0% $-58.53K $-58.53K $162.19K $220.73K
pp = percentage points